Transportability Analysis Methods for External Validity Assessment of Randomized Clinical Trial Evidence for Health Technology Assessment Decision-Making: A Simulation Study

Author(s)

Vuong Q1, Metcalfe R2, Yan R1, Park J1
1Core Clinical Sciences, Vancouver, BC, Canada, 2Core Clinical Sciences, Calgary, AB, Canada

OBJECTIVES: Randomized clinical trials (RCTs) are an important source of evidence for health technology assessment (HTA), but their external validity is often uncertain. Assessment of RCT external validity can facilitate decision making by improving the relevance of RCT evidence to local contexts. Transportability analyses are causal inference methods used to assess the validity of RCTs in external settings. We conducted a simulation study to assess the performance of two novel methods, inverse odds of participation weighting (IOPW) and g-computation, for transporting original RCT findings to real-world data (RWD).

METHODS: Datasets from RCT (study) and RWD (target) populations were generated with different distributions of covariates and effect modifiers and different true average treatment effects (ATEs) for a continuous outcome. We assumed that the treatment and response variables were only observed in the study dataset. IOPW and g-computation methods were each used to estimate the ATE in the target population using its covariate data. Bias, coverage of 95% confidence interval (CI), and relative error of standard error (SE) were used to compare the performance of IOPW and g-computation versus naïve linear regression.

RESULTS: Compared to the naïve estimator, the IOPW and g-computation estimators performed considerably better on all metrics. There was considerably less bias, and the 95% CIs of the target ATE calculated using IOPW and g-computation empirically met the nominal level. The relative errors of SE were small in all methods. The performance of the transportability analysis methods is contingent on specifying the models correctly when using IOPW and g-computation.

CONCLUSIONS: Transportability analysis is an important tool that can facilitate HTA decision making. As seen in our simulation study, transporting results from RCT to real-world settings using IOPW and g-computation methods show great promise. Challenges in the analysis include correctly specifying factors that affect treatment assignment in the RCT and modify the treatment effect.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Acceptance Code

P33

Topic

Health Technology Assessment, Methodological & Statistical Research, Study Approaches

Topic Subcategory

Clinical Trials, Confounding, Selection Bias Correction, Causal Inference, Decision & Deliberative Processes, Meta-Analysis & Indirect Comparisons

Disease

biologics-biosimilars, Drugs, Generics, Medical Devices

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×